Evolution of Immunoblastic Lymphoma in Angioimmunoblastic Lymphadenopathy

  • B. N. Nathwani
  • H. Rappaport
  • E. M. Moran
  • G. A. Pangalis
  • H. Kim
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 64)

Abstract

Angioimmunoblastic lymphadenopathy (AILD) [4, 5] or immunoblastic lymphadenopathy [7] is a systemic disease clinically characterized by fever, generalized lymphadenopathy, and hepatosplenomegaly. Polyclonal hypergammaglobulinemia, and Coombs’ positive hemolytic anemia are frequently present. The lymph nodes in AILD reveal a polymorphic picture consisting of a proliferation of small vessels, immunoblasts, and plasma cells. Similar clinical and histologic observations have been reported under other designations [3,10,14].

Keywords

Lymphoma Pneumonia Anemia Sarcoma Prednisone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fishe. R.I., Jaffe, E. S., Braylan, R. C., Andersen, J. C, Tan, H. K.: Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features. Amer. J. Med. 61 ,553 (1976).CrossRefGoogle Scholar
  2. 2.
    Flandrin, G.: Adénopathies angio-immunoblastiques avec anémie auto-immune et hyperimmuno-globulinémie polyclonale. Nouv. Presse Med. 5 ,1521 (1976).PubMedGoogle Scholar
  3. 3.
    Flandrin, G., Daniel, M. T., El Yafi, G., Chelloul, N.: Sarcomatoses ganglionnaires diffuses a différenciation plasmocytaire avec anémie hemolytique auto-immune. Actual. Haematol. (Paris) 6 ,25 (1972).Google Scholar
  4. 4.
    Frizzera, G., Moran, E. M., Rappaport, H.: Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1, 1070 (1974).PubMedCrossRefGoogle Scholar
  5. 5.
    Frizzera, G., Moran, E. M., Rappaport, H.: Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Amer. J. Med. 59 ,803 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    Howarth, C. B., Bird, C. C: Immunoblastic sarcoma arising in child with immunoblastic lymphadenopathy. Lancet 11 ,747 (1976).CrossRefGoogle Scholar
  7. 7.
    Lukes, R. J., Tindle, B. H.: Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. New Engl. J. Med. 292 ,1 (1975).PubMedCrossRefGoogle Scholar
  8. 8.
    Nathwani, B. N., Rappaport, H., Moran, E. M., Pangalis, G, A., Kim, H.:Malignant lymphoma arising in angio-immunoblastic lymphadenopathy. Cancer 41 ,578 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    Pruzanski, W., Sutton, D. M. C., Pantalony, D.: Angio-immunoblastic lymphadenopathy: An immunochemical study. Clin. Immunol. Immunopath. 6 ,62 (1976).CrossRefGoogle Scholar
  10. 10.
    Radaszkiewicz, T., Lennert, K.: Lymphogranulomatosis X. Dtsch. med. Wschr. 100 ,1157 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    Sternberger, L. A., Hardy, P. H., JR., Cuculis, J. J., Meyer, H. G.: The unlabeled antibody enzyme method of immunohistochemistry. J. Histochem. Cytochem. 18 ,315 (1970).PubMedCrossRefGoogle Scholar
  12. 12.
    Taylor, C. R.: An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin’s disease. Europ. J. Cancer 12 ,61 (1976).Google Scholar
  13. 13.
    Toth, J., Garam, T.: Immunoblastic lymphadenopathy proceeding to sarcoma. Lancet 1, 102 (1977).PubMedCrossRefGoogle Scholar
  14. 14.
    Westerhausen, M., Oehlert, W.: Chronisches pluripotentielles immunoproliferatives Syndrom. Dtsch. med Wschr. 97 ,1407 (1972).PubMedCrossRefGoogle Scholar
  15. 15.
    Yataganas, X., Papadimitriou, N., Pangalis, G. A., Loukopoulos, D., Fessas, Ph., Papachara-lampous, N.: Angio-immunoblastic lymphadenopathy terminating as Hodgkin’s disease. Cancer 59, 2183 (1977).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • B. N. Nathwani
  • H. Rappaport
  • E. M. Moran
  • G. A. Pangalis
  • H. Kim

There are no affiliations available

Personalised recommendations